|
?:authorAffiliation
|
-
[\'IncellDX, Menlo Park, CA, USA. Electronic address: brucep@incelldx.com.\', \'Montefiore Medical Center, New York, NY, USA.\', \'Amarex Clinical Research LLC, Germantown, MD, USA.\', \'Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.\', \'Quest Clinical Research, San Francisco, CA, USA.\', \'University of Hawaii, Honolulu, HI, USA.\', \'Vaccine & Gene Therapy Institute and Oregon National Primate Research Center, Oregon Health & Science University, Portland, OR, USA.\', \'IncellDX, Menlo Park, CA, USA.\', \'CytoDyn Inc., Vancouver, WA, USA.\', \'Beckman Coulter, Miami, FL, USA.\', \'Bio-Rad, Pleasanton, CA, USA.\', \'Amerimmune LLC, Fairfax, VA, USA.\', \'State University of New York-University Hospital of Brooklyn, NY, USA.\', \'Division of Infectious Diseases, Department of Internal Medicine, USA.\', \'Department of Emergency Medicine, Washington University in Saint Louis School of Medicine, Saint Louis, MO, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}